R
Rimsys
The first and only holistic Regulatory Information Management (RIM) software platform that consolidates all the functions of regulatory affairs, helping regulatory affairs professionals digitize…
About Rimsys
Rimsys is a company focused on modernizing regulatory affairs for the medical technology (medtech) industry. It serves clients in the medtech sector, including manufacturers and regulatory professionals, by providing a comprehensive platform that centralizes and automates regulatory processes. The company operates in the global regulatory market, addressing the complexities and frequent changes in regulations such as the EU MDR IVDR rollout. Rimsys' business model revolves around a SaaS (Software as a Service) platform that integrates with existing clinical, product, and quality systems within an organization. This platform offers features like automated alerts, notifications, and digital maintenance of essential principles tables, ensuring that all stakeholders have access to consistent and up-to-date information. Rimsys makes money through subscription fees for its platform, which helps clients increase regulatory affairs (RA) productivity, manage complexity, and reduce compliance risks. The company also offers consulting services to assist with administrative tasks, making it a cost-effective solution for its clients.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Pittsburgh, United States
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 73.6/100
- Industry
- Health, Legal
- Sub-industry
- Health Platform, RegTech & Compliance
- Sector
- Health Tech & Medtech, Hard Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Oct 2024 | $3M | — | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | Oct 2024 | $3M | $80M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Rimsys is 18K monthly website visits, up 20% over the last three months. Rimsys's team grew 3.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Allos Ventures
Series A5 investors entered at this stage
Pittsburgh Life Sciences Greenhouse
Innovation Works
Bessemer Venture Partners
GO PA Fund
Riverfront Ventures
Other known investors2 additional known investors
BlueTree Allied Angels
Eric Boduch
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Rimsys on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rimsys’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







